MAY 25, 2016 12:51 PM PDT

Lypd8 protects the gut from bacterial invasion

WRITTEN BY: Kerry Evans
Researchers at Osaka University identified a protein called Lypd8 that keeps bacteria from invading the cells that line the colon (in mice, at least). Their work also points to an important role for this protein in the development of ulcerative colitis, and Lypd8 could even be a therapeutic target for this inflammatory bowel disease (IBD).
 
Lypd8 may be a therapeutic target for IBD.

These Japanese researchers are particularly interested in IBD because cases of this disorder have increased greatly in Japan. Around 1.6 million Americans have been diagnosed with IBD, and there are around 70,000 new cases each year.

There’s quite a bit of evidence that links a dysfunctional intestinal mucosal barrier with IBD. For example, mice with defective mucosal barriers readily develop intestinal inflammation because bacteria are able to invade the cells that line the gut. Since there are tons of bacteria in the gut, it makes sense that there must be some mechanism to keep them at bay.

The group set about testing the role of a protein called Lypd8. This protein is produced by colonic epithelial cells and is secreted into the lumen of the intestine (in both mice and humans). Interestingly, the levels of Lypd8 are known to be lower in the colons of people with ulcerative colitis than in otherwise healthy people.

They found that intestinal bacteria passed through the mucus layer in the guts of Lypd8-deficient mice, suggesting that Lypd8 somehow protects the gut from bacterial invasion. Furthermore, the majority of these “invading” bacteria were species that use flagella to swim - like E. coli, P. mirabilis, and H. pylori.

Based on this finding, the group thought that Lypd8 might be inhibiting flagellar motility in these cells. Sure enough, they found that Lypd8 binds to flagella and also decreases the motility of P. mirabilis.

So, it looks like Lypd8 protects colonic epithelial cells from bacterial invasion by hampering the motility of the bacteria. Pretty cool!
 

Sources: Osaka University, Nature, Crohn’s and Colitis Foundation of America
 
About the Author
  • Kerry received a doctorate in microbiology from the University of Arkansas for Medical Sciences.
You May Also Like
MAR 23, 2020
Genetics & Genomics
MAR 23, 2020
Diagnosing Cancer by Looking for Microbial DNA in the Blood
Liquid biopsies aim to diagnose a disease with only a bit of biological fluid, usually blood.
MAY 04, 2020
Microbiology
MAY 04, 2020
How Soap and Hand Sanitizer Kill Viruses
The COVID-19 pandemic has spread around the world and there is still no available treatment or a vaccine. Prevention rem ...
MAY 18, 2020
Microbiology
MAY 18, 2020
An Antibody Against SARS May Neutralize SARS-CoV-2
SARS-CoV caused an outbreak of SARS in 2003. Samples collected from those patients back then may help us against SARS-Co ...
MAY 20, 2020
Cell & Molecular Biology
MAY 20, 2020
Researchers Detect a Vulnerability in Viruses
Myriad organisms share this planet, and there is an ongoing evolutionary arms race between competing traits or species, ...
MAY 23, 2020
Microbiology
MAY 23, 2020
The FDA Yanks Some COVID-19 Antibody Tests From the Market
The massive demand for diagnostic testing led the FDA to open a short window for many testing products to go to market w ...
JUN 01, 2020
Microbiology
JUN 01, 2020
The Most Common Marine Microbe Has a Virus in Its Genome
Single-celled ocean microbes known as Pelagibacter or SAR11 make up about 25 percent of the plankton on the planet.
Loading Comments...